Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
about
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesWhich Antibody Functions are Important for an HIV Vaccine?Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesHIV vaccine trial exploits a dual and central role for innate immunity.Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systemsGlycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plants.New prospects for a preventive HIV-1 vaccine.Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge.HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.Role of Fc-mediated antibody function in protective immunity against HIV-1.Highly individual patterns of virus-immune IgG effector responses in humans.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Non-Neutralizing Antibodies Directed against HIV and Their Functions.
P2860
Q24612811-DBAC8889-7006-4835-AF11-926B2A1FB97CQ33772637-7048B700-02CF-4ADC-8690-ADC4A137CED1Q34057711-CE3AE641-F614-4CBB-9F05-4982ED2CCC04Q34261579-7E4C820A-9042-44A6-AC4E-A940865C26D1Q34540352-1B3E1E8A-63D5-427B-83A3-964C28E87608Q34637663-7BE0103F-C86E-42A4-B787-115D45337307Q36179265-340F927B-4D58-4308-85C5-2D8EBD0D341AQ36223864-26F7C99D-69DA-4FA7-9E6B-62B46A4B8602Q36798324-CE3A29CA-9C90-462B-9D19-A0B030D980D6Q37484124-B3A233BA-6724-4E33-9DA5-65723F6C6CA3Q38061191-89CBBE47-B9F4-44E3-A1E6-4879F2319675Q38213061-501B24A2-03EA-4ACB-B87F-36BF223867D0Q38953491-342D3976-2EBB-4A8A-8246-8EBF849149B6Q39189458-B442B400-8EB0-469B-84F5-472C639ADFF2Q47139556-7DEEC708-9093-46E3-823B-249C362F04F6
P2860
Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@ast
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@en
type
label
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@ast
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@en
prefLabel
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@ast
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@en
P2093
P2860
P356
P1433
P1476
Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies
@en
P2093
Christiane Moog
Maryse Peressin
Vincent Holl
P2860
P304
P356
10.3390/V1031265
P577
2009-12-15T00:00:00Z